Cargando…

Association between interleukin-36γ and tumor progression in non-small cell lung cancer

Immunotherapy is effective in improving the survival and prognosis of patients with non-small cell lung cancer (NSCLC), and identifying effective immunomarkers is important for immunotherapy. Interleukin (IL)-36γ is a novel immunomarker that has an important function in the antitumor immune response...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Lin, He, Honghong, Xu, Dan, Feng, Yuehua, Zhou, Huijun, Shi, Liyan, Gu, Yanzheng, Wang, Jian, Zhu, Yibei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039103/ https://www.ncbi.nlm.nih.gov/pubmed/32194745 http://dx.doi.org/10.3892/ol.2020.11319

Ejemplares similares

Opposing Effects of Interleukin-36γ and Interleukin-38 on Trained Immunity
por: Teufel, Lisa U., et al.
Publicado: (2023)

Eomes Impedes Durable Response to Tumor Immunotherapy by Inhibiting Stemness, Tissue Residency, and Promoting the Dysfunctional State of Intratumoral CD8(+) T Cells
por: Sun, Runzi, et al.
Publicado: (2021)

Interleukin‐36α suppresses growth of non‐small cell lung cancer in vitro by reducing angiogenesis
por: Xie, Xiaoxiao, et al.
Publicado: (2021)

Interleukin(IL)-36α and IL-36γ Induce Proinflammatory Mediators from Human Colonic Subepithelial Myofibroblasts
por: Kanda, Toshihiro, et al.
Publicado: (2015)

A novel biomarker for pleural effusion diagnosis: Interleukin‐36γ in pleural fluid
por: Guo, Lun, et al.
Publicado: (2022)

Regulation of Interleukin-36γ/IL-36R Signaling Axis by PIN1 in Epithelial Cell Transformation and Breast Tumorigenesis
por: Poudel, Muna, et al.
Publicado: (2022)

The Effect of Interleukin 36 Gene Therapy in the Regression of Tumor
por: Solahaye-Kahnamouii, Shiva, et al.
Publicado: (2014)

Interleukin-36γ and IL-36 receptor signaling mediate impaired host immunity and lung injury in cytotoxic Pseudomonas aeruginosa pulmonary infection: Role of prostaglandin E2
por: Aoyagi, Tetsuji, et al.
Publicado: (2017)

Interleukin-36 Cytokines in Infectious and Non-Infectious Lung Diseases
por: Peñaloza, Hernán F., et al.
Publicado: (2021)

Interleukin-36γ is expressed by neutrophils and can activate microglia, but has no role in experimental autoimmune encephalomyelitis
por: Bozoyan, Lusine, et al.
Publicado: (2015)

Interleukin (IL)-1β Is a Strong Inducer of IL-36γ Expression in Human Colonic Myofibroblasts
por: Takahashi, Kenichiro, et al.
Publicado: (2015)

Thrombospondin-1 Restricts Interleukin-36γ-Mediated Neutrophilic Inflammation during Pseudomonas aeruginosa Pulmonary Infection
por: Peñaloza, Hernán F., et al.
Publicado: (2021)

Interleukin-36 in Infectious and Inflammatory Skin Diseases
por: Buhl, Anna-Lena, et al.
Publicado: (2019)

Expression of Concern: Interleukin (IL)-1β Is a Strong Inducer of IL-36γ Expression in Human Colonic Myofibroblasts
Publicado: (2023)

IL‐36γ and IL‐36Ra Reciprocally Regulate NSCLC Progression by Modulating GSH Homeostasis and Oxidative Stress‐Induced Cell Death
por: Wang, Peng, et al.
Publicado: (2021)

Small Molecule IL-36γ Antagonist as a Novel Therapeutic Approach for Plaque Psoriasis
por: Todorović, Viktor, et al.
Publicado: (2019)

IL-36 s in the colorectal cancer: is interleukin 36 good or bad for the development of colorectal cancer?
por: Chen, Feier, et al.
Publicado: (2020)

B7-H3 inhibits the IFN-γ-dependent cytotoxicity of Vγ9Vδ2 T cells against colon cancer cells
por: Lu, Huimin, et al.
Publicado: (2020)

Reduced interleukin-38 in non-small cell lung cancer is associated with tumour progression
por: Wang, Feng, et al.
Publicado: (2018)

Porphyromonas gingivalis exacerbates the progression of fatty liver disease via CD36-PPARγ pathway
por: Ahn, Ji-Su, et al.
Publicado: (2021)

Role of Interleukin 36 in Generalised Pustular Psoriasis and Beyond
por: Sugiura, Kazumitsu
Publicado: (2022)

The CD36-PPARγ Pathway in Metabolic Disorders
por: Maréchal, Loïze, et al.
Publicado: (2018)

Altered serum levels of IL-36 cytokines (IL-36α, IL-36β, IL-36γ, and IL-36Ra) and their potential roles in Guillain-Barré syndrome
por: Zhao, Zhikang, et al.
Publicado: (2020)

Long‐term prognostic significance of interleukin‐17‐producing T cells in patients with non‐small cell lung cancer
por: Song, Li, et al.
Publicado: (2019)

TIM-3 Expression Characterizes Regulatory T Cells in Tumor Tissues and Is Associated with Lung Cancer Progression
por: Gao, Xin, et al.
Publicado: (2012)

Interleukin-36γ is causative for liver damage upon infection with Rift Valley fever virus in type I interferon receptor-deficient mice
por: Anzaghe, Martina, et al.
Publicado: (2023)

Tumor-infiltrating CD36(+)CD8(+)T cells determine exhausted tumor microenvironment and correlate with inferior response to chemotherapy in non-small cell lung cancer
por: Ao, Yong-Qiang, et al.
Publicado: (2023)

Retraction ‘Reduced interleukin-38 in non-small cell lung cancer is associated with tumour progression’
por: Wang, Feng, et al.
Publicado: (2020)

Cytokine IL-36γ Improves CAR T Cell Functionality and Induces Endogenous Anti-Tumor Response
por: Li, Xinghuo, et al.
Publicado: (2020)

Elevated Interleukin-36α And CD4(+)IL-36α(+)T Cells Are Involved in the Pathogenesis of Graves' Disease
por: Yao, Qiu-ming, et al.
Publicado: (2018)

Plasma Levels of Interleukins 36α, 36β, and 37 in Patients with Psoriasis and Their Correlation with Disease Activity Parameters
por: Słucznowska-Głabowska, Sylwia, et al.
Publicado: (2022)

The role of interleukin-17 in tumor development and progression
por: Zhao, Junjie, et al.
Publicado: (2019)

Increased serum IL-36β and IL-36γ levels in patients with neuromyelitis optica spectrum disorders: association with disease activity
por: Yang, Chun-Sheng, et al.
Publicado: (2019)

Unprocessed interleukin-36α regulates psoriasis-like skin inflammation in co-operation with interleukin-1
por: Milora, Katelynn A., et al.
Publicado: (2015)

Expression of concern: Reduced interleukin-38 in non-small cell lung cancer is associated with tumour progression
por: Wang, Feng, et al.
Publicado: (2020)

Progress and application of circulating tumor cells in non-small cell lung cancer
por: Qian, Huizhu, et al.
Publicado: (2021)

Role of IL-36γ/IL-36R Signaling in Corneal Innate Defense Against Candida albicans Keratitis
por: Dai, Chenyang, et al.
Publicado: (2021)

Keratinocyte interleukin-36 receptor expression orchestrates psoriasiform inflammation in mice
por: Hernández-Santana, Yasmina E, et al.
Publicado: (2020)

NOD2 deficiency confers a pro‐tumorigenic macrophage phenotype to promote lung adenocarcinoma progression
por: Wang, Yibei, et al.
Publicado: (2021)

Aberrant expression of cytokine interleukin 9 along with interleukin 4 and interferon γ in connective tissue disease-associated interstitial lung disease: association with severity of pulmonary fibrosis
por: Jiang, Shan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_v1h1n3i71lj37n5f665ui03d1i